Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis
NCT00004682 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2015-03-25
Summary
OBJECTIVES:
I. Determine whether intravenous immunoglobulin is an effective therapy for patients with mild or moderate myasthenia gravis.
Conditions
Interventions
- DRUG
-
immune globulin
Sponsors & Collaborators
-
University of Texas
lead OTHER
Principal Investigators
-
Richard J. Barohn · University of Texas
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
Eligibility
- Min Age
- 15 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1995-03-31
- Completion
- 1999-03-31
More Related Trials
-
Efficacy and Safety Study of GB-0998 for Treatment of Generalized Myasthenia Gravis
NCT00515450 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of IGIV-C in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis
NCT02473965 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis
NCT03971422 ·Status: COMPLETED ·Phase: PHASE3
-
Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory Myopathies
NCT00001261 ·Status: COMPLETED ·Phase: PHASE2
-
Acupuncture in Myasthenia Gravis (AcuMG)
NCT05230082 ·Status: COMPLETED ·Phase: NA
-
Therapeutic Plasma Exchange in MG
NCT01927692 ·Status: COMPLETED
-
Mycophenolate Mofetil in Myasthenia Gravis
NCT00285350 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
NCT07039916 ·Status: RECRUITING ·Phase: PHASE3
-
An Open-label Study to Investigate the Clinical Efficacy of Different Dosing Regimens of Efgartigimod IV in Patients With Generalized Myasthenia Gravis
NCT04980495 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis
NCT07250750 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Multicentre randomiSed Controlled TRial of IntraVEnous Immunoglobulin Versus Standard Therapy for Transverse Myelitis
NCT02398994 ·Status: TERMINATED ·Phase: PHASE3
-
Add-on Intravenous Immunoglobulins in Early Myositis
NCT05832034 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia Gravis
NCT05451212 ·Status: COMPLETED ·Phase: PHASE1
-
Personalized Immunotherapeutic for Antibiotic-resistant Infection
NCT02508584 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Study of RVT-1401 in Myasthenia Gravis (MG) Patients
NCT03863080 ·Status: COMPLETED ·Phase: PHASE2
-
Intravenous Human IgG1 Fc Fragment (Efgartigimod) in Myasthenic Crisis
NCT06688253 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Myasthenia Gravis Inebilizumab Trial
NCT04524273 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Telitacicept and Low-dose Steroids in Refractory Myasthenia Gravis
NCT06723548 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis
NCT04124965 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Rozanolixizumab in Study Participants With Generalized Myasthenia Gravis
NCT04650854 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective Cohort Study of Myasthenia Gravis in China
NCT06006832 ·Status: RECRUITING
-
A Study to Assess the Efficacy and Safety of IGIV-C in Patients With Myasthenia Gravis Exacerbations
NCT02413580 ·Status: COMPLETED ·Phase: PHASE3
-
Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis
NCT00424489 ·Status: TERMINATED ·Phase: PHASE1
-
A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis
NCT06298552 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Pilot Trial of Rituxan in Refractory Myasthenia Gravis
NCT00619671 ·Status: COMPLETED ·Phase: PHASE1/PHASE2